Ameriprise’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
Other funds holding ASTH
3C
Ameriprise's ASTH Position: Q2 2026 in Review
Ameriprise reduced its Astrana Health (ASTH) stake by 7.2% in Q2 2026, selling an estimated $1.42M and leaving 512,110 shares worth $23.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1416.
Ameriprise first reported a position in ASTH in Q2 2021 and has held it in 21 quarters since. 210 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.
- Ameriprise held 512,110 shares of Astrana Health worth $23.8M as of Q2 2026.
- Ameriprise sold 39,489 Astrana Health shares in Q2 2026, an estimated $1.42M.
- Astrana Health made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #1416 holding.
- Ameriprise first reported a position in Astrana Health in Q2 2021 and has held it in 21 quarters since.
- 210 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.
Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.